Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0GP7 stock hub

LON/0GP7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0GP7is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

74.6M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0GP7

In the news

Latest news · LON/0GP7

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.2

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-61.6

P25 -54.2P50 2.1P75 13.7

ROIC-200

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0GP7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

163

Groups with data

Currency

SEK

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	UK
Employees	10
Employees Change	1%
Employees Change Percent	11.11
Enterprise value	SEK 63.2M
Exchange	London Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	SE0020181014
Last refreshed	2026-05-10
Market cap	SEK 74.6M
Price	SEK 1.77
Price currency	SEK
Rev Per Employee	71,666.1x
Sector	Healthcare
Sic	8731
Symbol	lon/0GP7
Website	https://www.medivir.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.66%
EV Earnings	-8.78x
EV/Sales	88.23x
Forward P/E	24.19x
P/B ratio	4.91x
P/S ratio	104.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	SEK -2.5M
Net Income	SEK -7.2M
Net Income Growth Years	1%
Pretax Margin	-1,004.89%
Profit Per Employee	SEK -720,162
ROA	-30.06
Roa5y	-24.62
ROCE	-45.09
ROE	-61.65
Roe5y	-50.9
ROIC	-200
Roic5y	-136.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-26.14%
Cagr15y	-23.1%
Cagr1y	11.14%
Cagr3y	-35.18%
Cagr5y	-22.93%
EPS Growth Quarters	8
EPS Growth Years	2
Revenue Growth	144.15x
Revenue Growth Q	522.85x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	24.5x
Revenue Growth5 Y	-16.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.05
Assets	SEK 18M
Cash	SEK 11.9M
Current Assets	SEK 9.9M
Current Liabilities	SEK 2.7M
Debt	SEK 509,286
Debt Equity	SEK 0.03
Equity	SEK 15.2M
Interest Coverage	-36.89
Liabilities	SEK 2.8M
Long Term Assets	SEK 8.1M
Long Term Liabilities	SEK 94,245
Net Cash	SEK 11.4M
Net Cash By Market Cap	SEK 15.23
Net Cash Growth	115.36%
Net Debt Equity	SEK -0.75
Tangible Book Value	SEK 9.9M
Tangible Book Value Per Share	SEK 0.02
WACC	6.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.34
Net Working Capital	SEK -2M
Quick ratio	5.34
Working Capital	SEK 9.9M
Working Capital Turnover	SEK 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-95.17%
1Y total return	11.13%
200-day SMA	11.75
3Y total return	-72.77%
50-day SMA	1.58
50-day SMA vs 200-day SMA	50under200
5Y total return	-72.8%
All Time High	147
All Time High Change	-98.8%
All Time High Date	2014-07-15
All Time Low	0.4
All Time Low Change	337.92%
All Time Low Date	2025-12-09
ATR	0.19
Beta	0.33
Ch YTD	337.9
High	1.77
High52	2.88
High52 Date	2026-03-16
High52ch	-38.54%
Low	1.77
Low52	0.4
Low52 Date	2025-12-09
Low52ch	337.92%
Ma50ch	12.05%
Price vs 200-day SMA	-84.96%
RSI	43.93
RSI Monthly	36.16
RSI Weekly	29.58
Sharpe ratio	-0.39x
Sortino ratio	-0.52
Total Return	-25.08%
Tr YTD	337.9
Tr15y	-98.05%
Tr1m	-25.44%
Tr1w	-1.56%
Tr3m	260.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -7.1M
Operating margin	-987.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	271,034,596%
Net Borrowing	-213,311.8
Shares Insiders	21.78%
Shares Institutions	13.96%
Shares Qo Q	97.86%
Shares Yo Y	25.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	153,332.15x
Bv Per Share	0.03
Ch10y	-96.75
Ch15y	-98.69
Ch1m	-25.44
Ch1w	-1.56
Ch1y	11.13
Ch3m	260.6
Ch3y	-77.69
Ch5y	-77.72
Ch6m	221.3
Change	-1.56%
Change From Open	0
Close	1.8
Days Gap	-1.56
Depreciation Amortization	6,765.5
Dollar Volume	1,060.2
Earnings Date	2026-04-29
EBIT	SEK -7.1M
EBITDA	SEK -7.1M
EPS	SEK -0.03
F Score	4
Financing CF	13,816,927
Fiscal Year End	December
Founded	1,987
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Ma150	4.25
Ma150ch	-58.41%
Ma20	2.28
Ma20ch	-22.36%
Net CF	9,070,382
Next Earnings Date	2026-08-20
Open	1.77
Ppne	553,098.4
Price Date	2026-05-08
Ptbv Ratio	7.53
Relative Volume	0x
Revenue	716,661x
Tr6m	221.27%
Volume	600

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0GP7 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0GP7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0GP7?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.0%

Share of float held by funds and institutions

Insider ownership

+21.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+25.1%

Negative means the company is buying back shares.

Technical

LON/0GP7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.9

Neutral momentum band

Price vs 200-day MA

-85.0%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

-0.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0GP7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0GP7 stock rating?

lon/0GP7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0GP7 analysis?

The full report lives at /stocks/lon/0GP7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0GP7?

The latest report frames lon/0GP7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0GP7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.